191 related articles for article (PubMed ID: 25544697)
1. Recombinant transferrin binding protein A (rTbpA) fragments of Pasteurella multocida serogroup B:2 provide variable protection following homologous challenge in mouse model.
Shivachandra SB; Yogisharadhya R; Kumar A; Mohanty NN; Nagaleekar VK
Res Vet Sci; 2015 Feb; 98():1-6. PubMed ID: 25544697
[TBL] [Abstract][Full Text] [Related]
2. Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of
Fegan JE; Waeckerlin RC; Tesfaw L; Islam EA; Deresse G; Dufera D; Assefa E; Woldemedhin W; Legesse A; Akalu M; Bayissa B; Nguyen QH; Ng D; Ahn SK; Schryvers AB; Tefera TA; Moraes TF; Gray-Owen SD
Front Immunol; 2024; 15():1392681. PubMed ID: 38835751
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis and cross-protective efficacy of recombinant 87 kDa outer membrane protein (Omp87) of Pasteurella multocida serogroup B:2.
Kumar A; Yogisharadhya R; Ramakrishnan MA; Viswas KN; Shivachandra SB
Microb Pathog; 2013 Dec; 65():48-56. PubMed ID: 24120691
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.
Muangthai K; Tankaew P; Varinrak T; Uthi R; Rojanasthien S; Sawada T; Sthitmatee N
J Vet Med Sci; 2018 Jan; 80(1):68-76. PubMed ID: 29109353
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of highly conserved recombinant VacJ outer membrane lipoprotein of Pasteurella multocida.
Shivachandra SB; Kumar A; Yogisharadhya R; Viswas KN
Vaccine; 2014 Jan; 32(2):290-6. PubMed ID: 24280281
[TBL] [Abstract][Full Text] [Related]
6. Specific antibodies of Pasteurella multocida in newborn calves of vaccinated dams.
el-Eragi AM; Mukhtar MM; Babiker SH
Trop Anim Health Prod; 2001 Jul; 33(4):275-83. PubMed ID: 11474861
[TBL] [Abstract][Full Text] [Related]
7. The ABA392/pET30a protein of Pasteurella multocida provoked mucosal immunity against HS disease in a rat model.
Kang TL; Velappan RD; Kabir N; Mohamad J; Rashid NN; Ismail S
Microb Pathog; 2019 Mar; 128():90-96. PubMed ID: 30584901
[TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy and cross-protectivity of a live intranasal aerosol haemorrhagic septicaemia vaccine.
Myint A; Jones TO; Nyunt HH
Vet Rec; 2005 Jan; 156(2):41-5. PubMed ID: 15675522
[TBL] [Abstract][Full Text] [Related]
9. Live haemorrhagic septicaemia vaccine for cattle and buffaloes.
Jones TO; Myint A; Carter GR
Vet Rec; 2002 Jan; 150(4):120. PubMed ID: 11838999
[No Abstract] [Full Text] [Related]
10. Immunisation of cattle and buffaloes with live haemorrhagic septicaemia vaccine.
Carter GR; Myint A; Van Khar R; Khin A
Vet Rec; 1991 Aug; 129(9):203. PubMed ID: 1957476
[No Abstract] [Full Text] [Related]
11. Immunity provided by haemorrhagic septicaemia-subunit vaccine in ruminants.
Maslog FS
Dev Biol Stand; 1998; 92():301-7. PubMed ID: 9554285
[TBL] [Abstract][Full Text] [Related]
12. Binding of bovine transferrin by Pasteurella multocida serotype B:2,5, a strain which causes haemorrhagic septicaemia in buffalo and cattle.
Veken JW; Oudega B; Luirink J; de Graaf FK
FEMS Microbiol Lett; 1994 Jan; 115(2-3):253-7. PubMed ID: 8138137
[TBL] [Abstract][Full Text] [Related]
13. Reverse vaccinology-based identification of a novel surface lipoprotein that is an effective vaccine antigen against bovine infections caused by Pasteurella multocida.
Islam EA; Fegan JE; Tefera TA; Curran DM; Waeckerlin RC; Ng D; Ahn SK; Lai CHR; Nguyen QH; Shah M; Tesfaw L; Adamu K; Medhin WW; Legesse A; Deresse G; Getachew B; Rawlyk N; Evans B; Potter A; Schryvers AB; Gray-Owen SD; Moraes TF
PLoS Pathog; 2023 Mar; 19(3):e1011249. PubMed ID: 36961851
[TBL] [Abstract][Full Text] [Related]
14. Intranasal inoculation of recombinant DNA vaccine ABA392 against haemorrhagic septicaemia disease.
Kang TL; Chelliah S; Velappan RD; Kabir N; Mohamad J; Nor Rashid N; Ismail S
Lett Appl Microbiol; 2019 Nov; 69(5):366-372. PubMed ID: 31508837
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B:2.
Ataei S; Burchmore R; Christopher Hodgson J; Finucane A; Parton R; Coote JG
Res Vet Sci; 2009 Oct; 87(2):207-10. PubMed ID: 19243798
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.
Hodgson JC; Finucane A; Dagleish MP; Ataei S; Parton R; Coote JG
Infect Immun; 2005 Mar; 73(3):1475-81. PubMed ID: 15731045
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of haemorrhagic septicaemia alum-precipitated vaccine.
Myint A; Jones TO
Vet Rec; 2007 Feb; 160(5):172. PubMed ID: 17277309
[No Abstract] [Full Text] [Related]
19. Interaction between Pasteurella multocida B:2 and its derivatives with bovine aortic endothelial cell (BAEC).
Kamal NM; Zamri-Saad M; Masarudin MJ; Othman S
BMC Vet Res; 2017 Jun; 13(1):186. PubMed ID: 28629460
[TBL] [Abstract][Full Text] [Related]
20. Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.
Dagleish MP; Hodgson JC; Ataei S; Finucane A; Finlayson J; Sales J; Parton R; Coote JG
Infect Immun; 2007 Dec; 75(12):5837-44. PubMed ID: 17875632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
